logo
logo

Cambridge Spinout Broken String Biosciences Raises $15M To Make Cell And Gene Therapies Safer And Affordable

Sep 18, 2023almost 2 years ago

Amount Raised

$15 Million

CambridgeBiotechnology

Investors

Arnaud AutretYoann BonnamourDieter Von Holtzbrinck VenturesTencentHeran PartnersMérieux Equity PartnersIllumina Ventures

Description

Now, Broken String Biosciences has picked up $15 million in Series A funding. The investment round was co-led by Illumina Ventures, which recently backed Lightcast Discovery and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures (DvH Ventures).  As part of the round, Yoann Bonnamour, Mérieux Equity Partners, and Arnaud Autret, Illumina Ventures, join the company’s Board of Directors.

Company Information

Company

String Biosciences

Location

Cambridge, Maryland, United States

About

Broken String Biosciences is a genomics company that is building a technology platform to drive the development of cell & gene therapies that are safer by design.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech